Findings from the UK Biobank reinforced these observations, showing that CHIP, particularly of myeloid lineage, was associated with an increased risk of CKD, with Mendelian randomization suggesting a possible causal relationship (p = 0.03). Here, STUB1 is linked to chronic kidney disease.